Why the study?
Optimal perioperative antithrombotic management in patients with acute coronary syndrome or scheduled for percutaneous coronary intervention remains unclear and is unaddressed in existing guidelines.
This consensus document provides case-based, evidence-based guidelines for the individualized perioperative management of antithrombotic therapy in patients with ACS or undergoing PCI, addressing a gap in current guidelines.
Answers are grounded in this paper and cite their sources.
Standardizes personalized perioperative antithrombotic strategies for ACS and PCI patients.
Given the progressive improvements in antithrombotic strategies, management of cardiovascular disease has become sophisticated/refined. However, the optimal perioperative management of antithrombotic therapy in patients with acute coronary syndrome or who are scheduled for percutaneous coronary intervention remains unclear. Assessments of the thrombotic and hemorrhagic risks are essential to reduce the rates of mortality and major cardiac events. However, the existing guidelines do not mention these topics. This case-based consensus document deals with common clinical scenarios and offers evidence-based guidelines for individualized perioperative management of antithrombotic therapy in the real world.
No takes yet. Share an insight, caveat, or question.
Park et al. (2022) conducted a review in Acute coronary syndrome or scheduled for percutaneous coronary intervention. Perioperative antithrombotic management was evaluated. Perioperative management of antithrombotic therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention is addressed through case-based, evidence-based guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: